Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $26.82 USD
Change Today 0.00 / 0.00%
Volume 113.1K
AMED On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

amedisys inc (AMED) Snapshot

Open
$26.90
Previous Close
$26.82
Day High
$27.19
Day Low
$26.64
52 Week High
02/27/15 - $31.27
52 Week Low
05/8/14 - $12.86
Market Cap
903.1M
Average Volume 10 Days
117.1K
EPS TTM
$0.63
Shares Outstanding
33.7M
EX-Date
--
P/E TM
42.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for AMEDISYS INC (AMED)

amedisys inc (AMED) Related Businessweek News

View More BusinessWeek News

amedisys inc (AMED) Details

Amedisys Inc. provides home health and hospice services including practical nursing services and physical and occupational therapy. The company’s services also comprise speech pathology, social work to help families address acute and chronic illnesses, home health aide services, and private duty services. Hospice services use a team made up of a physician, patient care manager, registered nurses, certified home health aides, social workers, a chaplain, a homemaker, and volunteers. As of Apr. 4, 2007, the company operated 261 Medicare-certified home health agencies and 14 Medicare-certified hospice agencies in 19 states. Amedisys was founded in 1982 and is headquartered in Baton Rouge, La.

13,200 Employees
Last Reported Date: 03/4/15
Founded in 1982

amedisys inc (AMED) Top Compensated Officers

Vice Chairman and Chief Financial Officer
Total Annual Compensation: $514.2K
Chief Compliance Officer and Corporate Counse...
Total Annual Compensation: $270.6K
Compensation as of Fiscal Year 2013.

amedisys inc (AMED) Key Developments

Amedisys Inc. Announces Executive Changes

Amedisys Inc. announced the company is adding a new Board member and implementing leadership changes at the executive level. Effective April 22, 2015, Bruce D. Perkins will become a member of the Company’s Board of Directors. Perkins spent 38 years at Humana Inc., most recently as President of Humana’s Healthcare Services Segment. Effective April 7, Vice Chairman, Ronnie LaBorde, will resume his role as Chief Financial Officer, and Interim Chief Financial Officer, Dale Redman, will retire. With this transition, Amedisys expects to enter into a consulting agreement with Redman under which he will continue to advise the Company. Executive additions include the appointment of Dan McCoy as the Chief Operating Officer, Martin Howard as Chief Information Officer, Larry Pernosky as Chief Human Resources Officer, Stephen Seim as Chief Strategy Officer and David Kemmerly as Senior Vice President of Government Affairs: Effective April 6, Dan McCoy joined the company as the Chief Operating Officer and will be responsible for home health and hospice operations. McCoy comes to Amedisys with more than 20 years of experience successfully leading operations and driving growth at major health plans. Most recently, McCoy served as the Senior Vice President of Operations at Anthem (formerly WellPoint). Effective April 6, Martin Howard has been appointed Chief Information Officer for Amedisys. He has 30 years of health care experience, including 20 years in the industry as a CIO and COO in organizations ranging from startups to Fortune 100 companies, and 10 years of Big Four M&A and performance consulting. Larry Pernosky will join the company on April 22 as Chief Human Resources Officer. Pernosky joins Amedisys with more than 30 years of experience in leading human capital strategies to drive superior business outcomes. In his most recent role as Vice President of Human Capital Consulting at Humana Inc.

Michael O. Fleming to Depart as Chief Medical Officer of Amedisys, Inc., Effective April 15, 2015

Effective April 15, 2015, Michael O. Fleming, Chief Medical Officer of Amedisys Inc., will depart the company to pursue other opportunities. The company expects to enter into a consulting agreement with Dr. Fleming on mutually acceptable terms to assist with the transition of his responsibilities.

Amedisys Inc. Reports Unaudited Consolidated Financial Results for the Fourth Quarter and Year Ended December 31, 2014

Amedisys Inc. reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported net service revenue of $300,528,000 compared to $303,497,000 a year ago. Operating income was $14,811,000 compared to operating loss of $10,362,000 a year ago. Income before income taxes was $14,519,000 compared to loss before income tax of $13,556,000 a year ago. Loss from continuing operations was $9,331,000 compared to income from continuing operations of $8,518,000 a year ago. Net income was $9,331,000 compared to net loss of $9,977,000 a year ago. Net income attributable to the company was $9,135,000 or $0.28 per basic and diluted share compared to net loss attributable to the company $9,628,000 or $0.30 per basic and diluted share a year ago. Amounts attributable to the company common stockholders income from continuing operations were $9,135,000 compared to amounts attributable to the company common stockholders loss from continuing operations $8,169,000 a year ago. Net cash provided by operating activities was $4,595,000 compared to $8,401,000 a year ago. EBITDA was $23,087,000 compared to LBITDA of $2,722,000 a year ago. Adjusted EBITDA was $22,873,000 compared to $6,786,000 a year ago. Adjusted net loss from continuing operations attributable to the company of $8,997,000 or $0.27 per diluted share compared to adjusted net loss from continuing operations of $2,239,000 or $0.07 per diluted share a year ago. For the year, the company reported net service revenue of $1,204,554,000 compared to $1,249,344,000 a year ago. Operating income was $24,047,000 compared to operating loss of $154,971,000 a year ago. Income before income taxes was $20,976,000 compared to loss before income taxes of $153,475,000 a year ago. Income from continuing operations was $13,305,000 compared to loss from continuing operations of $94,702,000 a year ago. Net income was $13,089,000 compared to net loss of $97,775,000 a year ago. Net income attributable to the company was $12,776,000 or $0.39 per basic and diluted share compared to net loss attributable to the company of $96,178,000 or $3.08 per basic and diluted share a year ago. Amounts attributable to the company common stockholders income from continuing operations were $12,992,000 compared to amounts attributable to the company common stockholders loss from continuing operations $93,105,000 a year ago. Net cash used in operating activities was $65,534,000 compared to net cash provided by operating activities of $102,263,000 a year ago. EBITDA was $57,093,000 compared to LBITDA of $110,649,000 a year ago. Adjusted EBITDA was $74,278,000 compared to $54,375,000 a year ago. Adjusted net income from continuing operations attributable to the company on guidance basis was $23,872,000 or $0.73 per diluted share compared to $5,221,000 or $0.16 per diluted share a year ago. Total capital expenditures was $12 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMED:US $26.82 USD 0.00

AMED Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Capital Senior Living Corp $26.68 USD +0.11
Chemed Corp $123.62 USD +0.08
Five Star Quality Care Inc $4.51 USD +0.01
National HealthCare Corp $64.53 USD +0.17
Ensign Group Inc/The $45.68 USD +0.32
View Industry Companies
 

Industry Analysis

AMED

Industry Average

Valuation AMED Industry Range
Price/Earnings 67.8x
Price/Sales 0.7x
Price/Book 2.3x
Price/Cash Flow 22.0x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMEDISYS INC, please visit www.amedisys.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.